Results 51 to 60 of about 5,158 (116)

Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real‐World International Experience

American Journal of Hematology, Volume 101, Issue 7, Page 1597-1604, July 2026.
ABSTRACT Sutimlimab is a monoclonal antibody against complement fraction C1s approved for the treatment of hemolytic anemia due to cold agglutinin disease (CAD). Here, we analyzed and report the largest international CAD cohort of sutimlimab‐treated patients ever reported to highlight its safety and effectiveness in the real‐world setting. We accrued a
Bruno Fattizzo, Elisa Sambruna, Yoshitaka Miyakawa, Marc Michel, Carlo Visco, Michael Fillitz, George Kannourakis, Maria Bruna Greve, Moritz Kleemiss, Johan Cid, Andrea Patriarca, Laura Pavan, Arbana Dizdari, Nilla Maschio, Antonella Sau, Cinzia Bitetti, Riccardo Mario Colombo, Luigi Curreli, Dorela Lame, Uros Markovic, Fabrizio Pappagallo, Giacinto Luca Pedone, Davide Rapezzi, Vincenzo Sammartano, Nicola Tumedei, Antonio Giovanni Solimando, Jalink Marit, Luana Fianchi, Jahanzaib Khwaja, Antonio De Vivo, Francesco Lanza, Fabrizio Vianello, Esther N. Oliva, Catherine Broome, Francesco Passamonti, Ulrich Jaeger, Bernd Jilma, Guillaume Moulis, Wilma Barcellini   +38 more
wiley   +1 more source

Compresión medular por metástasis de melanoma

Medicina Clínica Práctica, 2021
Jorge Esteban Villarrubia, Javier Torres Jiménez, Pablo Álvarez Ballesteros, Inmaculada Orejana Martín, Lucía Sanz Gómez, Juan José Soto Castillo, Elena Vida Navas, María Victoria San Román Gil, Javier Pozas Pérez, Ainara Soria Rivas   +9 more
doaj   +1 more source

Ibero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin: Recommendations for Clinical Practice

Cancer Management and Research, 2021
Agustín Falco,1 Thiago Bueno de Oliveira,2 Jon Cacicedo,3 Aylen Vanessa Ospina,4 Miguel Ángel Ticona,5 Héctor Galindo,6 Marcos David Pereira,7 José Luis Aguilar-Ponce,8 Antonio Rueda-Domínguez,9 Tannia Soria,10 Miren Taberna,11 Lara Iglesias,12 Taysser ...
Falco A, de Oliveira TB, Cacicedo J, Ospina AV, Ticona MÁ, Galindo H, Pereira MD, Aguilar-Ponce JL, Rueda-Domínguez A, Soria T, Taberna M, Iglesias L, Sowley T, Mesía R   +13 more
doaj  

Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM). [PDF]

ESMO Open, 2023
Pedrazzoli P, Lasagna A, Cassaniti I, Piralla A, Squeri A, Bruno R, Sacchi P, Baldanti F, Di Maio M, Beretta GD, Cinieri S, Silvestris N.   +11 more
europepmc   +1 more source

Editorial

ARS Medica, 2017
Sin ...
Boletín Escuela de Medicina
doaj   +1 more source

Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM). [PDF]

ESMO Open, 2022
Pedrazzoli P, Lasagna A, Cassaniti I, Ferrari A, Bergami F, Silvestris N, Sapuppo E, Di Maio M, Cinieri S, Baldanti F.   +9 more
europepmc   +1 more source

Síndrome de Fahr en paciente oncológico

Revista Cubana de Medicina Militar
Introducción: El síndrome de Fahr es una enfermedad rara y de baja incidencia, caracterizada por el desarrollo de depósitos de calcio en estructuras cerebrales, con cuadro un sintomático inespecífico y curso variable según su etiología.
Alejandro Manuel Perez Fonteboa, Danay Corrales Otero , Hector Montalvo Gonzalez, Lucien Bory Porras, Luis Enrqiue Alsina Tul, Claudia San Loys Bou, Karla Paiffer Sosa   +6 more
doaj  

COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave? [PDF]

ESMO Open, 2021
Silvestris N, Di Maio M, Russo A, Chiari R, De Giorgi U, Del Mastro L, Giuffrida D, La Verde N, Perrone F, Tucci M, Beretta GD, Cinieri S.   +11 more
europepmc   +1 more source

Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper. [PDF]

ESMO Open, 2021
Silvestris N, Argentiero A, Natalicchio A, D'Oronzo S, Beretta GD, Acquati S, Adinolfi V, Di Bartolo P, Danesi R, Faggiano A, Ferrari P, Gallo M, Gori S, Morviducci L, Russo A, Tuveri E, Zatelli MC, Montagnani M, Giorgino F.   +18 more
europepmc   +1 more source

Análisis de la situación epidemiológica y manejo actual de los sarcomas de tejido blando y hueso en el Hospital México, San José Costa Rica

Revista Clínica de la Escuela de Medicina UCR-HSJD, 2018
Antecedente: Los sarcomas de tejido blando y de hueso, sontumores raros, que son más frecuentes en la población joven. Existen varios subtipos y cada uno de ellos debe ser tratados en forma individual.
Raquel Rojas- Vigot, Denis U. Landaverde, Allan Ramos Esquivel   +2 more
doaj   +1 more source